Department of Defense Chemical and Biological Defense Program: Annual Report to Congress, April 2007 [open pdf - 6MB]
"The Chemical and Biological Defense Program (CBDP) provides U.S. forces the best capability and support in the world. The CBDP is a key component of national and defense strategies aimed at defending the nation from the hostile use of weapons of mass destruction (WMD)- particularly chemical and biological (CB) weapons- against U.S. citizens, military forces, friends, and allies. The CBDP seeks to ensure that Department of Defense (DoD) operations are unconstrained by chemical and/or biological effects by providing CB defense capabilities to build readiness for current and future challenges. The program depends on support in three priority areas: 1. Stable funding for the Transformational Medical Technologies Initiative (TMTI); 2. Adequate long-term investment in the Research, Development, Test, and Evaluation (RDT&E) infrastructure, including laboratories and test facilities; and 3. Consistent, predictable, and sustained resource levels for the CBDP. This annual report of the Department of Defense Chemical and Biological Defense Program describes how the Department is executing the CBDP and provides the context for a management framework that seeks to identify and balance investment priorities against risks over time. The report provides detailed information and assessments regarding: 1. the overall readiness of the armed forces to fight in a CB warfare environment, along with efforts undertaken and ongoing plans to improve such readiness; and 2. the requirements for the CBDP, including requirements for training, detection, protective equipment, decontamination equipment, medical prophylaxis, and treatment of casualties resulting from the use of CB weapons."